ArticleThe Journal of infectious diseases2026
Unexpected Variability in Laboratory and Clinical Assays Used to Quantify Cryptococcus neoformans Polysaccharide.
Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
The detection and quantification of cryptococcal capsular polysaccharide (PS) antigen in body fluids is useful for the diagnosis of cryptococcosis. We compared the sensitivity of 4 assays for measuring the amount of cryptococcal PS and 2 clinical assays (lateral flow assay [IMMY] and the cryptococcal latex agglutination assay [Remel]) using the PS of 4 single-motif-expressing Cryptococcus strains. These showed relatively consistent laboratory assay interstrain sensitivity with significant interstrain variation, with the more sensitive clinical assays showing variation consistent with antigenic differences. Analysis of lateral flow assay false-negative isolates reveals that cryptococcal PS motif expression is not recognized by the antibodies used in the assay. These results suggest that strain variation in PS structure affects the sensitivity of the various quantification tests, while antigen-antibody matching is essential to avoid false-negative results in cryptococcal antigen testing of bodily fluids. Including antibodies with higher specificity in clinical assays could reduce false-negative results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.